Although up until now there have been no studies that report RNA targeting by light-activated insulin, there have been many studies showing that light-activated drugs can hit RNA and epigenetic targets in cancer [84,109,111], which is an opportunity to be explored in experimental studies on T2D for scientific evidence. This evidence concerns the gene INS and type 2 diabetes mellitus.